Publication Date
| In 2025 | 0 |
| Since 2024 | 0 |
| Since 2021 (last 5 years) | 0 |
| Since 2016 (last 10 years) | 1 |
| Since 2006 (last 20 years) | 2 |
Descriptor
| Diseases | 2 |
| Medical Research | 2 |
| Patients | 2 |
| Risk | 2 |
| Advisory Committees | 1 |
| Caregivers | 1 |
| Chronic Illness | 1 |
| Community Involvement | 1 |
| Cooperation | 1 |
| Databases | 1 |
| Drug Therapy | 1 |
| More ▼ | |
Author
Publication Type
| Journal Articles | 2 |
| Reports - Descriptive | 2 |
Education Level
Audience
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Peer reviewed
Direct linkJenkins, Carolyn; Arulogun, Oyedunni Sola; Singh, Arti; Mande, Aliyu T.; Ajayi, Eric; Benedict, Calys Tagoe; Ovbiagele, Bruce; Lackland, Daniel T.; Sarfo, Fred Stephen; Akinyemi, Rufus; Akpalu, Albert; Obiako, Reginald; Melikam, Enzinne Sylvia; Laryea, Ruth; Shidali, Vincent; Sagoe, Kwamena; Ibinaiye, Philip; Fakunle, Adekunie Gregory; Owolabi, Lukman F.; Owolabi, Mayowa O. – Health Education & Behavior, 2016
Stroke is the leading cause of neurological hospital admissions in sub-Saharan Africa (SSA) and the second leading cause of death globally. The Stroke Investigative Research and Education Network [SIREN] seeks to comprehensively characterize the genomic, sociocultural, economic, and behavioral risk factors for stroke and to build effective teams…
Descriptors: Foreign Countries, Neurological Impairments, Medical Research, Health Education
Abbott, Natalie – Exceptional Parent, 2011
Of the nearly 7,000 rare diseases identified by the National Institutes of Health (NIH), only a few hundred currently have treatments. The development of therapies for rare diseases is often hampered by the special challenges of conducting the needed studies for rare disease drugs and medical devices, such as small numbers of patients and the fact…
Descriptors: Diseases, Patients, Nonprofit Organizations, National Organizations
